ID: ALA2437304

Max Phase: Preclinical

Molecular Formula: C15H23NO2

Molecular Weight: 249.35

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC1(C)ON=C(CC23CC4CC(CC(C4)C2)C3)O1

Standard InChI:  InChI=1S/C15H23NO2/c1-14(2)17-13(16-18-14)9-15-6-10-3-11(7-15)5-12(4-10)8-15/h10-12H,3-9H2,1-2H3

Standard InChI Key:  BJQAAMLKTYNMLW-UHFFFAOYSA-N

Associated Targets(non-human)

Botulinum neurotoxin type A 238 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 249.35Molecular Weight (Monoisotopic): 249.1729AlogP: 3.69#Rotatable Bonds: 2
Polar Surface Area: 30.82Molecular Species: NEUTRALHBA: 3HBD: 0
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 0.84CX LogP: 3.23CX LogD: 3.23
Aromatic Rings: 0Heavy Atoms: 18QED Weighted: 0.75Np Likeness Score: 0.22

References

1. Silhár P, Eubanks LM, Seki H, Pellett S, Javor S, Tepp WH, Johnson EA, Janda KD..  (2013)  Targeting botulinum A cellular toxicity: a prodrug approach.,  56  (20): [PMID:24127873] [10.1021/jm400873n]

Source